Acorn Bioventures
North America, New York, United States, New York
Description
Acorn Bioventures is a private and small capitalization biotech, specialty pharma and medical device companies.
Investor Profile
Acorn Bioventures has made 27 investments, with 1 in the past 12 months and 19% as lead.
Stage Focus
- Post Ipo Equity (48%)
- Series B (22%)
- Series C (15%)
- Series F (4%)
- Post Ipo Secondary (4%)
- Series A (4%)
- Series E (4%)
Country Focus
- United States (85%)
- United Kingdom (7%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Canada (4%)
- Switzerland (4%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Oncology
- Life Science
- Medical
- Pharmaceutical
- Biopharma
- Health Diagnostics
- Precision Medicine
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
